Zenas BioPharma, Inc. Common Stock (ZBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.89B
Last updated: Nov 17, 2026 at 4:33 PM ET
Zenas BioPharma, Inc. Common Stock (ZBIO) Stock Chart
Zenas BioPharma, Inc. Common Stock (ZBIO) has a latest price of $27.75 on Nov 17, 2026, 37.8% below its 52-week high of $44.60. Its price fell 20.7% over the past 12 months.
Price Chart
From Sep 2024 to Oct 2026, its highest month-end close was $38.83 in Nov 2025 and its lowest $7.01 in Feb 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ZBIO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ZBIO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.2%, and over 6 months it rose 55.5%.
| Period | Change |
|---|---|
| 1 month | +3.9% |
| 3 months | -11.2% |
| 6 months | +55.5% |
| 12 months | -20.7% |
| 12 months, with dividends | -20.7% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $28.39 | -21.8% |
| 2025 | $36.31 | +343.3% |
Trading Range
The price is 2.2% below its 50-day average of $28.38 and 9.1% above its 200-day average of $25.44.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.75 | |
| 52-week high | $44.60 | -37.8% |
| 52-week low | $13.50 | +105.6% |
| 50-day average | $28.38 | -2.2% |
| 200-day average | $25.44 | +9.1% |
Price Risk
Over 3 years, its largest fall from a peak was 75.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.72 |
| Largest fall, 1 year | -64.8% |
| Largest fall, 3 years | -75.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ZBIO
What is ZBIO's 1-year price change?
Zenas BioPharma, Inc. Common Stock's price fell 20.7% over the past 12 months. With dividends included, the 12-month total return was -20.7%.
What is ZBIO's 52-week high and low?
Zenas BioPharma, Inc. Common Stock's 52-week high is $44.60 and its 52-week low is $13.50. Its latest price of $27.75 on Nov 17, 2026 is 37.8% below the high.
What is ZBIO's beta?
Zenas BioPharma, Inc. Common Stock's 1-year beta against the S&P 500 is 0.72, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 64.8%.
Is the ZBIO chart free?
Yes. Advanced Charting for ZBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ZBIO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors